Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis

References

• XiaYQTianJChenXYEffect of surface properties on liposomal siRNA deliveryBiomaterials201679566826695117
   PubMed Web of Science ®Google Scholar
• ZhangJLiXHuangLNon-viral nanocarriers for siRNA delivery in breast cancerJ Control Release201419044045024874288
   PubMed Web of Science ®Google Scholar
• MainesFCaffoOVecciaASequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancerCrit Rev Oncol Hematol201596349850626318091
   PubMed Web of Science ®Google Scholar
• JiangKLiJYinJPTargeted delivery of CXCR4-siRNA by scFv for HER2+ breast cancer therapyBiomaterials201559778725956853
   PubMed Web of Science ®Google Scholar
• ChenZHYuTZhouBFMg(II)-Catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivoBiomaterials20168112513426731576
   PubMed Web of Science ®Google Scholar
• ChenYJGuHCZhangDSLiFLiuTXiaWHighly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrierBiomaterials20143538100581006925277774
   PubMed Web of Science ®Google Scholar
• LiTSYawataTHonkeKEfficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid–poly(ethylene glycol)–chitosan oligosaccharide lactate nanoparticles: For the potential targeted ovarian cancer gene therapyEur J Pharm Sci201452486124178005
   PubMed Web of Science ®Google Scholar
• FiorentiniCBodeiSBedussiFGPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activityExp Cell Res2014323110011124589892
   PubMedGoogle Scholar
• OzpolatBSoodAKLopez-BeresteinGLiposomal siRNA nanocarriers for cancer therapyAdv Drug Deliver Rev201466110116
   PubMed Web of Science ®Google Scholar
• XuCFWangJDelivery systems for siRNA drug development in cancer therapyAsian J Pharm Sci201510112
   Web of Science ®Google Scholar
• RanRLiuYYGaoHLPEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapyJ Pharm Sci201510447648425256603
   PubMed Web of Science ®Google Scholar
• SuzukiYHyodoKTanakaYIshiharaHsiRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivoJ Control Release2015220part A445026478014
   PubMedGoogle Scholar
• GomesMJMartinsSSarmentoBsiRNA as a tool to improve the treatment of brain diseases: Mechanism, targets and deliveryAgeing Res Rev201521435425796492
   PubMed Web of Science ®Google Scholar
• RanRLiuYYGaoHLEnhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: A potential candidate for overcoming multi-drug resistanceInt J Pharm20144771–259060025448564
   PubMed Web of Science ®Google Scholar
• HeBWWangYTShaoNMChangHChengYPolymers modified with double-tailed fluorous compounds for efficient DNA and siRNA deliveryActa Biomater201502211111925937003
   PubMedGoogle Scholar
• FredeANeuhausBKlopfleischRColonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivoJ Control Release2016222869626699423
   PubMed Web of Science ®Google Scholar
• GanasCWeißANazarenusMBiodegradable capsules as non-viral vectors for in vitro delivery of PEI/siRNA polyplexes for efficient gene silencingJ Control Release201419613213825451543
   PubMed Web of Science ®Google Scholar
• MisraRDasMSahooBSSahooSKReversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulationInt J Pharm20144751–237238425178825
   PubMedGoogle Scholar
• ZhengNSongZYLiuYRedox-responsive, reversibly-crosslinked thiolated cationic helical polypeptides for efficient siRNA encapsulation and deliveryJ Control Release201520523123925683619
   PubMedGoogle Scholar
• ZhongJHuangHLLiJDevelopment of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cellsHepatobiliary Pancreat Dis Int2015141828925655295
   PubMedGoogle Scholar
• MaoSRSunWKisselTChitosan-based formulations for delivery of DNA and siRNAAdv Drug Deliver Rev20106211227
   PubMed Web of Science ®Google Scholar
• ParkSJeongEJLeeJRhimTLeeSKLeeKYPreparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA deliveryCarbohyd Polym20139215762
   Google Scholar
• SharmaKSomavarapuSColombaniAGovindNTaylorKMNebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary deliveryInt J Pharm201345524124723876499
   PubMed Web of Science ®Google Scholar
• GuţoaiaASchusterLMarguttiSFine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivityCarbohyd Polym20161432534
   Google Scholar
• ZhengJNXieHGYuWTChitosan-g-MPEG-modified alginate/chitosan hydrogel microcapsules: A quantitative study of the effect of polymer architecture on the resistance to protein adsorptionLangmuir201026171561716420949965
   PubMed Web of Science ®Google Scholar
• MalhotraMTomaro-DuchesneauCPrakashSSynthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseasesBiomaterials20133441270128023140978
   PubMed Web of Science ®Google Scholar
• LeeDWYunKSBanHSChoeWLeeSKLeeKYPreparation and characterization of chitosan/polyguluronate nanoparticles for siRNA deliveryJ Control Release2009139214615219567259
   PubMed Web of Science ®Google Scholar
• RagelleHVandermeulenGPréaVTChitosan-based siRNA delivery systemsJ Control Release2013172120721823965281
   PubMed Web of Science ®Google Scholar
• RagelleHRivaRVandermeulenGChitosan nanoparticles for siRNA delivery: Optimizing formulation to increase stability and efficiencyJ Control Release2014176546324389132
   PubMed Web of Science ®Google Scholar
• HefniHHHAzzamEMBadrEASynthesis, characterization and anticorrosion potentials of chitosan-g-PEG assembled on silver nanoparticlesInt J Biol Macromol20168329730526645144
   PubMed Web of Science ®Google Scholar
• KimHKDavaaEMyungCSParkJSEnhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipidInt J Pharm20103921–214114720347025
   PubMed Web of Science ®Google Scholar
• RajeswariAAmalrajAPiusAAdsorption studies for the removal of nitrate using chitosan/PEG and chitosan/PVA polymer compositesJ Water Process Eng20169123134
   Web of Science ®Google Scholar
• PreethiTAbarnaBRajarajeswariGRInfluence of chitosan–PEG binary template on the crystallite characteristics of sol–gel synthesized mesoporous nano-titania photocatalystAppl Surf Sci201431719097
   Google Scholar
• LiuSHuangWJinMJFanBXiaGMGaoZGInhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEIEur J Pharm Sci20168217118226554721
   PubMed Web of Science ®Google Scholar
• LuoKWYueGGLKoCHIn vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinomaPhytomedicine2014218–91078108724856767
   PubMedGoogle Scholar
• YangFFHuangWLiYFAnti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticlesBiomaterials201334225689569923632321
   PubMed Web of Science ®Google Scholar
• SubramanianAManigandanASivashankariPRSethuramanSDevelopment of nanotheranostics against metastatic breast cancer: A focus on the biology & mechanistic approachesBiotechnol Adv20153381897191126454168
   PubMedGoogle Scholar
• TangSYinQSuJHInhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxelBiomaterials20154811525701027
   PubMed Web of Science ®Google Scholar
• SouzaCMSilvaACAFerraciolliCJCombination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer modelBiomed Pharmacother2014681515724054045
   PubMedGoogle Scholar